STAT+: U.K. unveils recommendations for regulating AI in medicine — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- A U.K. commission unveiled recommendations Thursday in London for how the country should regulate artificial intelligence in medicine
- The 44 recommendations focus on continuously reviewing ever-changing AI products after they reach the market instead of clearing them only once for authorization
- Some recommendations would allow staged authorization of new AI models, creating incremental checkpoints rather than a single approval gate
- A proposed provider reporting system would let clinics flag when AI tools malfunction or potentially inhibit patient care as the models learn and adapt
- The report highlighted AI's potential to process millions of scans — including those tracking eye health in diabetes patients — while stressing safety, performance tracking, and equitable treatment
- The commission acknowledged that AI models perform differently depending on the setting, framing that variability as a core regulatory challenge
Why it matters: For medical AI developers and U.K. health providers, the 44 recommendations signal a shift from one-time approval to ongoing oversight — meaning products would face continuous scrutiny as they evolve and are deployed across different clinical settings.
Ask SkimNews
